LexDanaLexDanabeta
Inventor

Lixin Qiao

Inventor
Tewksbury, MA, US

Overview

42→
Patents
1999–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 42 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
A61KPreparations for medical, dental or toiletry purposes24%
C07DHeterocyclic compounds21%
C12NMicroorganisms or enzymes8%
C07KPeptides7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C12YEnzymes5%
C07CAcyclic or carbocyclic compounds2%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
11,098,061MK2 inhibitors and uses thereof202110,828,300Substituted 2,4-diaminopyrimidines as kinase inhibitors202010,662,195Protein kinase conjugates and inhibitors202010,596,1722,4-disubstituted pyrimidines useful as kinase inhibitors202010,406,163Compounds that enhance Atoh1 expression201910,138,256MK2 inhibitors and uses thereof201810,010,5482,4-disubstituted pyrimidines useful as kinase inhibitors20189,987,276Substituted 2,4-diaminopyrimidines as kinase inhibitors20189,980,964ERK inhibitors and uses thereof20189,796,700'ERK inhibitors and uses thereof'20179,694,086'HCV protease inhibitors and uses thereof'20179,676,785'HCV protease inhibitors and uses thereof'20179,561,228'ERK inhibitors and uses thereof'20179,556,426'Protein kinase conjugates and inhibitors'20179,504,686'ERK inhibitors and uses thereof'20169,433,610'Compounds that enhance Atoh1 expression'20169,422,333'HCV protease inhibitors and uses thereof'20169,409,921'2,4-disubstituted pyrimidines as kinase inhibitors'20169,296,737'Substituted 2,4-diaminopyrimidines as kinase inhibitors'20169,212,181'Substituted 2,4-diaminopyrimidines as kinase inhibitors'20159,163,061'HCV protease inhibitors and uses thereof'20159,145,387'ERK inhibitors and uses thereof'20158,980,935'HCV protease inhibitors and uses thereof'20158,927,545'Inhibiting Eph B-3 kinase'20158,859,597'Compounds that enhance Atoh1 expression'20148,778,877'HCV protease inhibitors and uses thereof'20148,741,837'HCV protease inhibitors and uses thereof'20148,710,222'2,4-disubstituted pyrimidines useful as kinase inhibitors'20148,609,679'2,4-diaminopyrimidines useful as kinase inhibitors'20138,524,760'HCV protease inhibitors and uses thereof'20138,450,335'2,4-disubstituted pyrimidines useful as kinase inhibitors'20138,354,116'Bifunctional synthetic molecules'20138,338,439'2,4-disubstituted pyrimidines useful as kinase inhibitors'20128,309,685'HCV protease inhibitors and uses thereof'20128,293,705'HCV protease inhibitors and uses thereof'20128,188,137'HCV protease inhibitors and uses thereof'20128,188,131'Compounds that enhance Atoh1 expression'20127,153,843'Inhibitors of phosphatidyl myo-inositol cycle'20066,667,340'Inhibitors of phosphatidyl myo-inositol cycle'20036,562,783'Phosphinylmethyl and phosphorylmethyl succinic and glutauric acid analogs as -secretase inhibitors'20036,284,784'Substituted 2-pyrrolidinone activators of PKC'20015,962,504'Substituted 2-pyrrolidinone activators of PKC'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2001Based in Washington, DC, US· patent location history
2003–2006Based in Arlington, VA, US· patent location history
2012–2020Patents assigned to CELGENE AVILOMICS RES INC (19)· patent assignee history
2012–2017Patents assigned to QIAO LIXIN (14)· patent assignee history
2012–2017Patents assigned to NIU DEQIANG (10)· patent assignee history
2012–2017Patents assigned to SINGH JUSWINDER (10)· patent assignee history
2012–2020Based in Tewksbury, MA, US· patent location history
2012–2021Based in Andover, MA, US· patent location history
2017–2021Patents assigned to CELGENE CAR LLC (11)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CELGENE AVILOMICS RES INC192012–2020
QIAO LIXINself142012–2017
CELGENE CAR LLC112017–2021
NIU DEQIANG102012–2017
SINGH JUSWINDER102012–2017
Locations
LocationPatentsSpan
Tewksbury, Massachusetts, US242012–2020
Andover, Massachusetts, US132012–2021
Arlington, Virginia, US32003–2006
Washington, DC, US21999–2001